Literature DB >> 12115719

Mitochondria, the killer organelles and their weapons.

Luigi Ravagnan1, Thomas Roumier, Guido Kroemer.   

Abstract

Apoptosis is a cell-autonomous mode of death that is activated to eradicate superfluous, damaged, mutated, or aged cells. In addition to their role as the cell's powerhouse, mitochondria play a central role in the control of apoptosis. Thus, numerous pro-apoptotic molecules act on mitochondria and provoke the permeabilization of mitochondrial membranes. Soluble proteins contained in the mitochondrial intermembrane space are released through the outer membrane and participate in the organized destruction of the cell. Several among these lethal proteins can activate caspases, a class of cysteine proteases specifically activated in apoptosis, whereas others act in a caspase-independent fashion, by acting as nucleases (e.g., endonuclease G), nuclease activators (e.g., apoptosis-inducing factor), or serine proteases (e.g., Omi/HtrA2). In addition, mitochondria can generate reactive oxygen species, following uncoupling and/or inhibition of the respiratory chain. The diversity of mitochondrial factors participating in apoptosis emphasizes the central role of these organelles in apoptosis control and unravels novel mechanisms of cell death execution. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115719     DOI: 10.1002/jcp.10111

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  111 in total

Review 1.  Mitochondria-centric activation induced cell death of cytolytic T lymphocytes and its implications for cancer immunotherapy.

Authors:  Arvind Chhabra
Journal:  Vaccine       Date:  2010-05-06       Impact factor: 3.641

2.  Substoichiometric shifting in the plant mitochondrial genome is influenced by a gene homologous to MutS.

Authors:  Ricardo V Abdelnoor; Ryan Yule; Annakaisa Elo; Alan C Christensen; Gilbert Meyer-Gauen; Sally A Mackenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-01       Impact factor: 11.205

3.  The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function.

Authors:  James S Gibbs; Daniela Malide; Felicita Hornung; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

4.  Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death.

Authors:  Susan S Chou; Michael S Clegg; Tony Y Momma; Brad J Niles; Jodie Y Duffy; George P Daston; Carl L Keen
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

Review 5.  Interplay between mitochondria and cellular calcium signalling.

Authors:  Jake Jacobson; Michael R Duchen
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

6.  Application of a homogenous membrane potential assay to assess mitochondrial function.

Authors:  Srilatha Sakamuru; Xiao Li; Matias S Attene-Ramos; Ruili Huang; Jianming Lu; Louie Shou; Min Shen; Raymond R Tice; Christopher P Austin; Menghang Xia
Journal:  Physiol Genomics       Date:  2012-03-20       Impact factor: 3.107

Review 7.  Death receptor signals to mitochondria.

Authors:  Roya Khosravi-Far; Mauro Degli Esposti
Journal:  Cancer Biol Ther       Date:  2004-11-18       Impact factor: 4.742

8.  Region-specific interrelations between apoptotic proteins expression and DNA fragmentation in the neonatal rat brain.

Authors:  Petr N Menshanov; Anita V Bannova; Nikolay N Dygalo
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

Review 9.  MicroRNAs regulate the chaperone network in cerebral ischemia.

Authors:  Yi-Bing Ouyang; Rona G Giffard
Journal:  Transl Stroke Res       Date:  2013-08-17       Impact factor: 6.829

10.  Dichamanetin inhibits cancer cell growth by affecting ROS-related signaling components through mitochondrial-mediated apoptosis.

Authors:  Yeonjoong Yong; Susan Matthew; Jennifer Wittwer; Li Pan; Qi Shen; A Douglas Kinghorn; Steven M Swanson; Esperanza J Carcache DE Blanco
Journal:  Anticancer Res       Date:  2013-12       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.